Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study

por Walter, Margot J. M., Kuijper, T. M., Hazes, J. M. W., Weel, A. E., Luime, J. J.
Publicado 2018

The number of risk factors for persistent disease determines the clinical course of early arthritis

por Luurssen-Masurel, N, Weel, A E A M, Koc, G H, Hazes, J M W, de Jong, P H P
Publicado 2021

Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging t...

por Quax, R. A. M., Koper, J. W., Huisman, A. M., Weel, A., Hazes, J. M. W., Lamberts, S. W. J., Feelders, R. A.
Publicado 2015

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

por de Jong, P H, Hazes, J M, Han, H K, Huisman, M, van Zeben, D, van der Lubbe, P A, Gerards, A H, van Schaeybroeck, B, de Sonnaville, P B, van Krugten, M V, Luime, J J, Weel, A E
Publicado 2014